BS EN ISO 10993-3:2026

This standard BS EN ISO 10993-3:2026 Biological evaluation of medical devices is classified in these ICS categories:

• 11.100.20 Biological evaluation of medical devices

This document specifies strategies for risk estimation and evaluation of biological harms with respect to: genotoxicity; carcinogenicity; reproductive toxicity; and developmental toxicity. This document is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity has been established. This document is not applicable to active pharmaceutical ingredients of device-drug combination products or biological components of device-biologic combination products which are covered by regulations. NOTE            Guidance on selecting relevant biological effects for medical devices is covered in ISO 10993-1.

BS EN ISO 10993-3:2026 - Biological Evaluation of Medical Devices

Introducing the BS EN ISO 10993-3:2026, a comprehensive standard that plays a crucial role in the biological evaluation of medical devices. This standard is essential for ensuring the safety and efficacy of medical devices by evaluating their potential genotoxicity, carcinogenicity, reproductive toxicity, and developmental toxicity.

Key Features

• Standard Number: BS EN ISO 10993-3:2026
• Pages: 56
• Release Date: October 8, 2026
• ISBN: 978 0 539 44186 4
• Status: Standard

Overview

The BS EN ISO 10993-3:2026 standard is an integral part of the ISO 10993 series, which is dedicated to the biological evaluation of medical devices. This particular part of the series focuses on the assessment of potential risks associated with genotoxicity, carcinogenicity, reproductive toxicity, and developmental toxicity. These evaluations are critical for determining the safety of medical devices before they reach the market.

Importance of Biological Evaluation

Biological evaluation is a fundamental aspect of medical device development. It ensures that devices are safe for human use and do not pose any biological risks. The BS EN ISO 10993-3:2026 standard provides a framework for conducting these evaluations, helping manufacturers identify and mitigate potential hazards associated with their products.

Genotoxicity

Genotoxicity refers to the potential of a substance to damage genetic information in cells, which can lead to mutations and cancer. The BS EN ISO 10993-3:2026 standard outlines methods for assessing the genotoxic potential of medical devices, ensuring that they do not pose a risk to genetic material.

Carcinogenicity

Carcinogenicity is the ability of a substance to cause cancer. This standard provides guidelines for evaluating the carcinogenic potential of medical devices, helping to ensure that they do not contribute to the development of cancer in patients.

Reproductive and Developmental Toxicity

Reproductive toxicity refers to the adverse effects of a substance on reproductive health, while developmental toxicity pertains to the impact on the development of an organism. The BS EN ISO 10993-3:2026 standard includes protocols for assessing these risks, ensuring that medical devices are safe for use by individuals of reproductive age and do not harm developing embryos or fetuses.

Who Should Use This Standard?

The BS EN ISO 10993-3:2026 standard is essential for medical device manufacturers, regulatory bodies, and testing laboratories. It provides a comprehensive framework for evaluating the biological safety of medical devices, ensuring compliance with international regulations and standards.

Benefits of Compliance

Compliance with the BS EN ISO 10993-3:2026 standard offers numerous benefits, including:

• Enhanced Safety: Ensures that medical devices are safe for human use, reducing the risk of adverse biological effects.
• Regulatory Compliance: Helps manufacturers meet international regulatory requirements, facilitating market access.
• Improved Product Quality: Encourages the development of high-quality medical devices that meet stringent safety standards.
• Increased Consumer Confidence: Builds trust among healthcare professionals and patients by demonstrating a commitment to safety and quality.

Conclusion

The BS EN ISO 10993-3:2026 standard is a vital tool for ensuring the biological safety of medical devices. By providing a comprehensive framework for evaluating genotoxicity, carcinogenicity, reproductive toxicity, and developmental toxicity, this standard helps manufacturers develop safe and effective products that meet international regulatory requirements. Whether you are a manufacturer, regulatory body, or testing laboratory, the BS EN ISO 10993-3:2026 standard is an essential resource for ensuring the safety and efficacy of medical devices.